Cigarette Smoking Behaviors and Beliefs in Persons Living With Hepatitis C

Shuter, Jonathan; Litwin, Alain H.; Sulkowski, Mark S.; Feinstein, Addi; Bursky-Tammam, Avram; Maslak, Stephen; Weinberger, Andrea H.; Esan, Hannah; Segal, Kate S.; Norton, Brianna L.

doi:10.1093/ntr/ntw212

Cited by 11 publications

(13 citation statements)

References 34 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The national sample described herein and one earlier paper reporting on a small cohort from the Bronx, New York 32 indicate that hepatitis C+ smokers possess various characteristics that may interfere with successful quitting. Black race, low socioeconomic status, lower educational attainment, psychiatric illness, and comorbid substance use are all associated with lower cessation rates, and these factors also suggest the need for intensive tobacco treatment rather than brief interventions.…”

Section: Discussionmentioning

confidence: 61%

Cigarette Smoking in Persons Living with Hepatitis C: The National Health and Nutrition Examination Survey (NHANES), 1999-2014

Kim

Weinberger

Chander³

et al. 2018

The American Journal of Medicine

Self Cite

View full text Add to dashboard Cite

show abstract

Section: Discussionmentioning

confidence: 61%

Cigarette Smoking in Persons Living with Hepatitis C: The National Health and Nutrition Examination Survey (NHANES), 1999-2014

Kim

Weinberger

Chander³

et al. 2018

The American Journal of Medicine

Self Cite

View full text Add to dashboard Cite

show abstract

“…Additionally, very little research has explored correlates of cigarette smoking among people with HCV. These available studies have identified older age, alcohol use, use of illicit substances, and experiencing pain [15,16] as correlates of cigarette smoking among HCV patients.…”

Section: Introductionmentioning

confidence: 99%

Factors and HCV treatment outcomes associated with smoking among people who inject drugs on opioid agonist treatment: secondary analysis of the PREVAIL randomized clinical trial

et al. 2020

Self Cite

View full text Add to dashboard Cite

Background Cigarette smoking has emerged as a leading cause of mortality among people with hepatitis C virus (HCV). People who inject drugs (PWID) represent the largest group of adults infected with HCV in the US. However, cigarette smoking remains virtually unexplored among this population. This study aimed at (1) determining prevalence and correlates of cigarette smoking among HCV-infected PWID enrolled in opiate agonist treatment programs; (2) exploring the association of smoking with HCV treatment outcomes including adherence, treatment completion and sustained virologic response (SVR); and 3) exploring whether cigarette smoking decreased after HCV treatment. Methods Participants were 150 HCV-infected PWID enrolled in a randomized clinical trial primarily designed to test three intensive models of HCV care. Assessments included sociodemographics, presence of chronic health and psychiatric comorbidities, prior and current drug use, quality of life, and HCV treatment outcomes. Results The majority of the patients (84%) were current cigarette smokers at baseline. There was a high prevalence of psychiatric and medical comorbidities in the overall sample of PWID. Alcohol and cocaine use were identified as correlates of cigarette smoking. Smoking status did not influence HCV treatment outcomes including adherence, treatment completion and SVR. HCV treatment was not associated with decreased cigarette smoking. Conclusions The present study showed high prevalence of cigarette smoking among this population as well as identified correlates of smoking, namely alcohol and cocaine use. Cigarette smoking was not associated with HCV treatment outcomes. Given the detrimental effects that cigarette smoking and other co-occurring, substance use behaviors have on HCV-infected individuals’ health, it is imperative that clinicians treating HCV also target smoking, especially among PWID. The high prevalence of cigarette smoking among PWID will contribute to growing morbidity and mortality among this population even if cured of HCV. Tailored smoking cessation interventions for PWID along with HCV treatment may need to be put into clinical practice. Trial registration NCT01857245. Registered May 20, 2013.

show abstract

“…Moreover, researches indicated that hypertension, heart failure and diabetes were the most common comorbidities of chronic obstructive pulmonary disease, importantly, the incidence of patients with at least one comorbidity was 84.5% [7]. Furthermore, researchers indicated that there is a correlation between smoking and hepatitis C virus infection in the United States [8]. For infectious diseases, chronic hepatitis B virus (HBV) and hepatitis C virus (HCV) are a major global health burden, which usually results in liver cirrhosis and hepatocellular carcinoma (HCC) [9–11].…”

Section: Introductionmentioning

confidence: 99%

Niacin, lutein and zeaxanthin and physical activity have an impact on Charlson comorbidity index using zero-inflated negative binomial regression model: National Health and Nutrition Examination Survey 2013–2014

et al. 2019

View full text Add to dashboard Cite

Background: Combined with the increasing life expectancy, chronic medical conditions have gradually become the dominant cause of death and disability, and multimorbidity became an increasingly serious public health challenge. However, most existing studies have focused on the coexistence of specific diseases or relatively few diseases. Given one person may have multiple diseases at the same time, we applied Charlson Comorbidity Index (CCI) to systematically evaluate one's 10-year mortality. In this study, we explored the effects of nutrients and physical activity on CCI using National Health and Nutrition Examination Survey (NHANES) 2013-2014 data. Methods: The study sample consists of one continuous cycle (2013-2014) of NHANES, and 4386 subjects were included in the study. Nutrients intake was measured by dietary recall, and physical activity was evaluated by the Global Physical Activity Questionnaire respectively. Besides, CCI was the sum of the scores assigned for each medical condition. We utilized zero-inflated negative binomial (ZINB) model to investigate the effects in nutrients intake and physical activity on CCI by adjusting for seven sociodemographic characteristics, smoking and drinking. Results: Among the 4386 participants, 2018 (68.7%) are Non-Hispanic White, over half participants (78.6%) drink. In count part (CCI ≥ 0), holding other variables constant, the expected change in CCI for a one-unit increase in niacin is 1.621(RR = 1.621, p = 0.016), in lutein + zeaxanthin is 0.974 (RR = 0.974, p = 0.031), and in sedentary time is 1.035 (RR = 1.035, p = 0.005). Moreover, those who do not have vigorous work activity would be more likely to have higher CCI than those who have (RR = 1.275, P = 0.045). In logit part (CCI = 0), the log odds of having CCI equals zero would increase by 0.541 and 0.708 for every additional vigorous recreational activity (OR = 0.541, p = 0.004) and moderate recreational activity (OR = 0.708, p = 0.017) respectively. Conclusions: Lutein and zeaxanthin intake, vigorous work activity, vigorous recreational activity and moderate recreational activity may be good for one's health. Rather, increasing niacin intake and sedentary activity may be likely to raise 10-year mortality. Our findings may be significant for preventing diseases and improving health, furthermore, reducing people's financial burden on healthcare.

show abstract

Cigarette Smoking Behaviors and Beliefs in Persons Living With Hepatitis C

Cited by 11 publications

References 34 publications

Cigarette Smoking in Persons Living with Hepatitis C: The National Health and Nutrition Examination Survey (NHANES), 1999-2014

Cigarette Smoking in Persons Living with Hepatitis C: The National Health and Nutrition Examination Survey (NHANES), 1999-2014

Factors and HCV treatment outcomes associated with smoking among people who inject drugs on opioid agonist treatment: secondary analysis of the PREVAIL randomized clinical trial

Niacin, lutein and zeaxanthin and physical activity have an impact on Charlson comorbidity index using zero-inflated negative binomial regression model: National Health and Nutrition Examination Survey 2013–2014

Contact Info

Product

Resources

About